ABsTRAcr The effect of intravenous aminophylline on the contractile function of the diaphragm was studied in four normal subjects. The contractility of the diaphragm was assessed by the measurement of transdiaphragmatic pressure (Pdi) after right phrenic nerve stimulation at 1 Hz. Pdi was measured before and during aminophylline infusion (6 mg/kg over 30 minutes), during which therapeutic concentrations of theophylline were attained (mean 13.8 
Methylxanthines are commonly used to treat patients with airways obstruction and have a beneficial action in relaxing airway smooth muscle and stimulating the central nervous system.' These drugs are also known to act on skeletal muscle, producing appreciable potentiation of twitch force in vitro at millimolar concentrations.2 It has been suggested that aminophylline in therapeutic dosage may also reduce or reverse respiratory muscle fatigue. 3 Muscle fatigue characterised by a selective reduction of force in response to low or moderate frequencies of excitation (less than 30 Hz) with preservation of force at higher frequencies (50-100 Hz) develops in limb muscles with prolonged high work loads. 4 This low frequency fatigue reflects diminished twitch tension. During experimental sessions stimulation was performed at 100-150 volts with square wave unidirectional pulses of 50 microsecond duration at about 1 Hz (Digitimer 3072). Small changes in the position of the stimulating electrode altered the evoked muscle action potential and twitch Pdi height, but once the optimal position was found it was possible to maintain this for many minutes with reproducible maximum responses. Voltage was increased until the twitch Pdi height was maximal and increased voltage did not then increase the Pdi response.
Aminophylline was administered via a right forearm vein in a dose 6 mg/kg, 250 mg being given over the first 10 minutes and the remainder over the next 20 minutes. In one subject (No 2), in whom a total dose of 6 mg/kg over 30 minutes repeatedly gave. theophylline concentrations at the lower end of the therapeutic range, a further study using 7. 10, 20 , and 30 minutes. During these periods of stimulation venous blood samples were withdrawn for theophylline estimation.
MEASUREMENTS
The study could not be performed blind because of the symptoms produced by aminophylline given acutely. Electrical stimulation techniques, however, preclude any effect of motivation. To elimination bias during measurement the paper records were reproduced, coded, and analysed without knowledge of which twitches were from the control and which from the aminophylline periods. Twitch Pdi height was measured only at end expiration as indicated by the magnetometer positions and Pg and Poes. The evoked muscle action potential deflection was measured from peak to peak and twitch Pdi height was measured from baseline to peak. Pdi twitches were discarded if they were not at end expiration, were not associated with a maximal evoked muscle action potential, or were marred by pressure artefact-that is, oesophageal contractions. With these strict exclusion criteria 10-20% of twitches were satisfactory. The single maximum twitch height before and during aminophylline infusion was tabulated for each study, and also the mean values from the analysis of all twitches that satisfied the measurement criteria.
Results
An example of the transdiaphragmatic pressure twitch responses before and after aminophylline administered to a therapeutic concentration is shown in figure 2 The measurement of twitch height is a conventional technique of assessing muscle contractility and we therefore chose to study the twitch Pdi height rather than the response to higher stimulation frequencies. In preliminary studies we found that during a single experimental session on a particular subject the twitch height was less variable than the Pdi from phrenic nerve stimulation at higher frequencies.8 Experiments on muscle strips show that large concentrations of theophylline maximally potentiate twitch tension, having progressively less effect at high stimulation frequencies, and do not significantly increase tension at 100 Hz. 2 There are two possible factors which may influence the twitch Pdi and affect its value for detection of the action qf theophylline on 4iaphragm contractility. Firstly, theophylline could-reduce the contraction speed of muscle and prolong relaxation rate, thereby potentiating force at 20 Hz without any detectable increase in twitch height. In vitro studies of limb muscle and diaphragm, however, show that methyl xanthines have little effect on contraction speed,2 and for adductor pollicis therapeutic concentrations of theophylline do not affect maximum relaxation rate.'4 Twitch Pdi height could be affected by the frequency response of the measuring 291 and recording system. The frequency at which the response of the recording system was reduced by 3 decibels (F3dB) was measured and was at least 20 Hz. Any possible influence of frequency response was estimated by inserting a low pass filter into the recorder-display chain. The filter cut off was progressively reduced and the effect on Pdi height measured by superimposing filtered and unfiltered twitch Pdi images on the oscilloscope screen. The F3dB of the low pass filter was reduced to 12 Hz before any reduction in twitch height or shape was seen, which suggests that there were no significant frequency components above 12 Hz. The frequency response of the measuring and recording system is therefore unlikely to have obscured an increase in twitch -Pdi.
It is possible that owing to the complexity of studying the human diaphragm a small effect of the drug has not been detected but an important potentiating action is unlikely to They were able to show that the xanthines greatly potentiated twitch tension and consequently abolished the effects of low frequency fatigue when given in millimolar concentrations. At 0.1 millimolar concentrations, however, they detected no significant effect and concluded that theophylline at therapeutic concentrations would be unlikely to improve muscle contractility, an observation supported by the present study. Several recent in vivo animal studies have suggested that aminophylline does improve diaphragm contractility.'0-'3 Sigrist et al'0 studied the effect of aminophylline on the relationship between the diaphragm electromyogram (Edi) and transdiaphragmatic pressure in cats and concluded that for a given Edi aminophylline increases Pdi. Aminophylline was given in high dosagg (up to 120 mg/kg), however, and it did not significantly increase the Pdi/Edi ratio until a dose of 20 mg/kg, which corresponded to a theophylline concentration of 22-24 mg/l. On the basis of their data any beneficial effect of aminophylline at a therapeutic blood level (10-20 mg/l) would be small, about 10%.
Aubier et aP performed an important investigation on the action of aminophylline on diaphragm contractility in man. They reported that therapeutic concentrations of theophylline significantly improved the contractility of the fresh diaphragm and protected the diaphragm from low frequency fatigue, and when low frequency fatigue was experimentally produced aminophylline completely reversed it. The results of this study are thus similar to those of the animal in vitro study of Jones et al2 but were produced with one tenth the theophylline concentration. Wiles et al'4 set out to repeat the experimental protocol of Aubier et al, working on the adductor pollicis because force can be recorded with great precision for this muscle. These workers found that at therapeutic theophylline concentrations intravenous aminophylline had no effect on twitch tension or the frequency-force curve and no effect on the development or reversal of low frequency fatigue. Although it is possible that the diaphragm may be more sensitive to the action of aminophylline than adductor pollicis this seems unlikely , since Jones et al found that various skeletal muscles responded in the same way when studied in vitro.
There is clearly a discrepancy between the results of our study and much of the previously published work. This paradox is not easily explained. There may be species differences and differences between the sensitivity to aminophylline of different muscles as well as differences in experimental protocols. Further in vivo human studies are required before a final judgement is possible on the magnitude of any effect of aminophylline on the diaphragm.
From the present study we conclude that the diaphragm responds to aminophylline in much the same way as other skeletal muscles. High concentrations that would be toxic clinically may well potentiate twitch tension and reverse low frequency fatigue, but at therapeutic concentrations we found aminophylline to have no substantial direct effect on the contractile properties of the diaphragm of normal subjects.
